WELCOME TO FLAGSHIP BIOTECH INTERNATIONAL PVT LTD . FLAGSHIP - - PowerPoint PPT Presentation

WELCOME TO

FLAGSHIP BIOTECH INTERNATIONAL PVT LTD.

FLAGSHIP BIOTECH INTERNATIONAL PVT. LTD

An INDO – US PHARMA PHENOMENON An INDO – US PHARMA PHENOMENON

FLAGSHIP BIOTECH INTERNATIONAL 2

COMPANY PROFILE

• FLAGSHIP BIOTECH INTERNATIONAL PVT. LTD. is fully integrated Pharmaceutical

company with an established Marketing Network across the globe in 75 countries.

• Established in 2009
• Headquarter office in Navi-Mumbai
• Branch offices in western India & Global Subsidiary offices in USA & Mexico
• More than 700 pharmaceutical Formulations
• Operates in more than 75 countries worldwide having more than 400 products

registered.

• Achieved a Marketing excellence in the Branded Generics - Ethical, API, Formulations, OTC &

Institutional segments Globally & has emerged as a respectable name in the Global Pharmaceutical & Healthcare Arena.

FLAGSHIP BIOTECH International 3

Provide quality generics for Emerging markets at affordable prices using Global Standards.

VISION

Gain leadership positions in Acute & Chronic specialty therapy in India & other developing nations.

MISSION

 Focus on Quality Product and Customer Satisfaction.  Applying creative ideas for business improvement and growth

• pportunities.

 Delivering outstanding results + High standards of Performance

VALUES

FLAGSHIP BIOTECH INTERNATIONAL 4

2010-2011 2011-2012 2012-2013 2013-2014 2014-2015

4 7 14 22 31

Turnover

31 47 71 106 159 237

5 years Projection

GROWTH Overview in span of 5 years

Flagship Biotech International Sales revenues Exceeding 31 Crore with a CAGR of 51% over the last five years.

FLAGSHIP BIOTECH INTERNATIONAL 5

Unique Features of company

 Flagship is one of the few supplier in India which provides unique, orphan drug hard

to find medicine

 Growing company in shorter span of time-comparing other company  One of the fastest growing company of Indian Origin in Central American of

Caribbean region

 In Just short period, Flagship acquired a medium size pharmaceutical company in

2015

 Customer satisfaction-with variety of different customers in faster time  In shorter span of time highly penetrated into all export markets  Highly emerged company

FLAGSHIP BIOTECH INTERNATIONAL 6

Our Niche Products:



Alprostadil Injection



Dimenhydrinate Injections



Fluphenazone Decanoate Injection



Hydralazine Hydrochloride Injection & Tablet



Indomethacin Injection



Labetalol Injection



L-ornithine L-aspartate Injection



Dextrose Injection



Vasopressin Injection



Atenolol Injection



Benzotropine Injection & Tablet



Milirinone Injection



Nitroglycerine Injection



Octreotide Injection



Protamine Sulphate Injection



Suxamethonium Injection



Zuclopenthixol Injection



Terlipressin Injection

FLAGSHIP BIOTECH INTERNATIONAL 7

International benchmark - quality and regulatory systems

Quality – That defines Excellence

Innovation, Quality, Service

REGULATORY AFFAIRS

• This objective is achieved by Local & International Rules and

Regulations applicable to our operations.

• Flagship awarded with the ISO 9001: 2008 and with an outstanding

track record for maintaining Quality.

• This objective is achieved by Local & International Rules and

Regulations applicable to our operations.

• Flagship awarded with the ISO 9001: 2008 and with an outstanding

track record for maintaining Quality.

• We possess capabilities for preparing, Technical Dossiers and Drug Master Files (DMFs) for

a range of our products.

• We have registered more than 400 products.
• 250 CTD Dossiers registered in Asia, Africa, Latin America, CIS , Australia & Pacific Ocean

& 215 Products are in Pipeline.

• We possess capabilities for preparing, Technical Dossiers and Drug Master Files (DMFs) for

a range of our products.

• We have registered more than 400 products.
• 250 CTD Dossiers registered in Asia, Africa, Latin America, CIS , Australia & Pacific Ocean

& 215 Products are in Pipeline.

FLAGSHIP BIOTECH INTERNATIONAL 8

Contract Manufact cturing and nd Out lice censing g Service

OUR BUSINESS IS SUPPL Y OF YOUR INNOVATIVE PRODUCTS

• Reliable supply with products that meet the highest-

quality standards and integrated project management systems that ensure on-time delivery.

• From Kilogram to Multi-Tons Capabilities.
• Cost-effective & customized Manufacturing at our Plant
• Complete Regulatory Documentation Support.
• We Seek out-licensing opportunities for our generic

formulations for global markets.

• Excellent regulatory track record .
• Reliable supply with products that meet the highest-

quality standards and integrated project management systems that ensure on-time delivery.

• From Kilogram to Multi-Tons Capabilities.
• Cost-effective & customized Manufacturing at our Plant
• Complete Regulatory Documentation Support.
• We Seek out-licensing opportunities for our generic

formulations for global markets.

• Excellent regulatory track record .

Our Global CMO include :

FLAGSHIP BIOTECH INTERNATIONAL 9

Our Esteemed customer few of them:

 Medicuba  Pharmacuba  Ministry of Health Srilanka  Ministry of Health Sychelles  Ministry of Health Dominican Republic  Ministry of Health Guyana  Ministry of Health Trinidad and Tobago  Ministry of Health Bahamas

FLAGSHIP BIOTECH INTERNATIONAL 10

Rese sear arch and Development Research and Development

We believe that Research and Innovation are the key success factors for the growth of the company.  Formulation development for International Markets  Dedicated Regulatory Team for global filings  Dossier development  Chemical synthesis,  Process optimization,  Analytical Development  Conducting Stability Studies.  Formulation development for International Markets  Dedicated Regulatory Team for global filings  Dossier development  Chemical synthesis,  Process optimization,  Analytical Development  Conducting Stability Studies.

Our R & D capabilities include : Our R & D capabilities include :

FLAGSHIP BIOTECH INTERNATIONAL 11

ASIA:  MIDDLE EAST – Egypt, Iraq, Iran, Jordan, Lebanon Syria  South East – Afghanistan, Hong Kong, Indonesia, Malaysia, Maldives, Myanmar, Philippines, Srilanka, Taiwan , Vietnam. AFRICA: Angola, Benin, Burkina Faso, Egypt, Ethiopia, Ghana, Kenya, Liberia, Morocco, Mauritius, Madagascar, Mali, Mozambique, Nigeria, Sierra Leone, Senegal, Seychelles, South Africa, Uganda, Zambia, Zimbabwe. LATIN AMERICA- Barbados, Bolivia, Cuba, Costa Rica, Chile ,Dominican Republic, Ecuador ,El Salvador, Guatemala ,Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Peru, Paraguay, Suriname, Trinidad &Tobago, Uruguay, Venezuela. CIS – Belarus, Kazakhstan, Russia, Ukraine. AUSTRALIA & PACIFIC OCEAN – Fiji ,New Zealand, Papua New Guiana.

Our Global Footprint OF flagship Biotech International in 75 countries

Global Pr Prese sence

FLAGSHIP BIOTECH INTERNATIONAL 12

FLAGSHIP BIOTECH INTERNATIONAL 13

AFRICA

Angola, Benin, Burkina Faso, Egypt, Ethiopia, Ghana, Kenya, Liberia, Libya Morocco, Mauritius, Madagascar, Mali, Mozambique, Nigeria, Sierra Leone, Senegal, Seychelles, South Africa, Uganda, Zambia, Zimbabwe,Namibia,Congo,Equador LATIN AMERICA Barbados, Bolivia, Cuba, Costa Rica, Chile ,Dominican Republic, Ecuador ,El Salvador, Guatemala ,Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Peru, Paraguay, Suriname, Trinidad &Tobago, Uruguay, Venezuela.

ASIA

 MIDDLE EAST – Egypt, Iraq, Iran, Jordan, Lebanon Syria  South East – Afghanistan, Hong Kong, Indonesia, Malaysia, Maldives, Myanmar, Philippines, Srilanka, Taiwan , Vietnam.

AUSTRALIA & PACIFIC OCEAN

Fiji ,New Zealand, Papua New Guiana.

CIS

Belarus, Kazakhstan, Russia, Ukraine.

Gl Global Presen ence

Marketing - Broadest Portfolio of high quality of Generic Product

VETERINARY HORMONES ONCOLOGY BETA LACTAM ANTIBIOTICS SPECIALITY INJECTABLES NASAL PREPARATIONS EYE & EAR PREPARATIONS GENERAL TABLETS & CAPSULES LARGE VOLUME PARENTERALS ACTIVE PHARMACEUTICAL INGREDIENTS

FLAGSHIP BIOTECH INTERNATIONAL 14

Our Manufacturing site…..

FLAGSHIP BIOTECH INTERNATIONAL 15

Our Plant-Approval & Certificates

 IS0 9001  WHO-GMP  cGMP  NAFDAC-Nigeria, Cambodia, Srilanka &

Uganda/Kenya in progress.

FLAGSHIP BIOTECH INTERNATIONAL

Our plant- (WHO-GMP CERTIFIED COMPANY) we are expert in;

• New drugs
• Contract manufacturing
• Formulation development
• New product development
• Specialty Products
• Injectable
• Ophthalmic preparations
• Veterinary product
• Derma-medicated soap

FLAGSHIP BIOTECH INTERNATIONAL 17

Our Plant Manufacturing capability

 Manufacturing of (vials & ampoules)from 1ml to 99 ml  3piece Eye, Ear & Nasal drops  Tubes & bottles  Veterinary Injections 100ml as well

FLAGSHIP BIOTECH INTERNATIONAL

Available Dosage form with capacity

NO. Dosage form Capacity 1

Ampoules 50,000/shift

2

Vials 50,000/shift

3

Cream and ointment 20,000Tubes/shift

4

Ophthalmic 50,000/day

FLAGSHIP BIOTECH INTERNATIONAL 19

Therapeutic presence

• Cardiology
• Anti-infective
• Pain therapy
• Anti-osteoporosis
• Anti-asthma
• Antimalarial
• Veterinary
• Derma-medicated soap/cream/ointment/lotion

FLAGSHIP BIOTECH INTERNATIONAL 20

Pharmaceuticals formulation

 GENERAL TABLETS & CAPSULES  VETERINARY  SPECIALITY INJECTABLES  EXTERNAL PREPARATIONS  ANTIBOTICS  NASAL PREPARATIONS  GEL  DENTAL PRODUCTS  HORMONES  EYE & EAR PREPARATIONS

FLAGSHIP BIOTECH INTERNATIONAL 21

Our esteemed clients:

FLAGSHIP BIOTECH INTERNATIONAL 22

OFFICE A ADR DRES ESSES ES

MUMBAI OFFICE

1204 & 1302,Rupa solitaire , plot A-1, Sector – 1,MBP, T.T.C. Indl, Mahape, Navi Mumbai-400710, Tel : + 91 22 27781651 /652/653/654 Email id :- flagshipbiotech@gmail.com

U.S .OFFICE

8180 NW 36 Street, STE 100 City of Doral ,State Florida -33166, Email id :- fb-usa@flagshipbiotech.com

MEXICO OFFICE

Street: Venustiano Carranza s/n, Community :Luis Donaldo Colosio , District: Ecatepec De Morelos, Zip: 55029, State : Estado De Mexico

www.flagshipbiotech.com

FLAGSHIP BIOTECH INTERNATIONAL 23

FLAGSHIP BIOTECH INTERNATIONAL 24